Publications
- Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 +32013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hypertriglyceridemia and cardiovascular risk2012 | First Faculty of Medicine
- Principles of therapy of dyslipidemia in general practice2012 | First Faculty of Medicine
- The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus2012 | First Faculty of Medicine
- Prevention of atherosclerosis2010 | First Faculty of Medicine
- The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus2009 | First Faculty of Medicine, Faculty of Science
- Ivabradin, heart rate and cardiovascular risk. A commentary on the BEAUTIFUL trial2009 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Pharmacogenetics of statin treatment - can it be tailored?2009 | First Faculty of Medicine
Loading network view...